Janus Henderson Group PLC acquired a new position in Novadaq Technologies Inc. (NASDAQ:NVDQ) (TSE:NDQ) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 2,786,932 shares of the medical research company’s stock, valued at approximately $32,663,000. Janus Henderson Group PLC owned approximately 4.82% of Novadaq Technologies at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of NVDQ. Gamco Investors INC. ET AL bought a new stake in Novadaq Technologies in the 2nd quarter valued at about $145,000. Virtu Financial LLC bought a new stake in Novadaq Technologies in the 2nd quarter valued at about $157,000. Envestnet Asset Management Inc. increased its position in Novadaq Technologies by 12.9% in the 1st quarter. Envestnet Asset Management Inc. now owns 25,374 shares of the medical research company’s stock valued at $197,000 after buying an additional 2,898 shares in the last quarter. Wolverine Trading LLC bought a new stake in Novadaq Technologies in the 2nd quarter valued at about $254,000. Finally, GABELLI & Co INVESTMENT ADVISERS INC. bought a new stake in Novadaq Technologies in the 2nd quarter valued at about $255,000. 75.38% of the stock is owned by hedge funds and other institutional investors.

A number of analysts recently commented on NVDQ shares. Craig Hallum lowered Novadaq Technologies from a “buy” rating to a “hold” rating and set a $11.75 target price for the company. in a research report on Monday, June 19th. Canaccord Genuity lowered Novadaq Technologies from a “buy” rating to a “hold” rating and set a $11.75 target price for the company. in a research report on Monday, July 10th. Wedbush lowered Novadaq Technologies from an “outperform” rating to a “neutral” rating in a research report on Monday, June 19th. Stifel Nicolaus lowered Novadaq Technologies from a “buy” rating to a “hold” rating and set a $11.75 target price for the company. in a research report on Tuesday, June 20th. Finally, Zacks Investment Research lowered Novadaq Technologies from a “hold” rating to a “sell” rating in a research report on Wednesday, July 5th. One analyst has rated the stock with a sell rating, thirteen have issued a hold rating and two have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of $11.86.

Shares of Novadaq Technologies Inc. (NVDQ) opened at 11.75 on Tuesday. The firm’s 50-day moving average price is $11.68 and its 200-day moving average price is $9.03. The company’s market capitalization is $679.41 million. Novadaq Technologies Inc. has a one year low of $5.84 and a one year high of $12.74.

WARNING: “Janus Henderson Group PLC Invests $32.66 Million in Novadaq Technologies Inc. (NVDQ)” was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece of content on another site, it was copied illegally and republished in violation of US & international trademark & copyright law. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/10/17/janus-henderson-group-plc-invests-32-66-million-in-novadaq-technologies-inc-nvdq.html.

Novadaq Technologies Profile

NOVADAQ Technologies Inc is a medical device company. The Company primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed.

Want to see what other hedge funds are holding NVDQ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Novadaq Technologies Inc. (NASDAQ:NVDQ) (TSE:NDQ).

Institutional Ownership by Quarter for Novadaq Technologies (NASDAQ:NVDQ)

Receive News & Stock Ratings for Novadaq Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novadaq Technologies Inc. and related stocks with our FREE daily email newsletter.